ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2412

Evaluation of the Pretest Probability Score, Ultrasound and Biopsy on GCA Diagnose: Data from Real Clinical Practice

María del Carmen San José Méndez1, Uxía Couto Lareo1, Vanesa Balboa Barreiro2, Francisco J. Blanco1, Bruno de aspe de la iglesia1, Antonio Atanes Sandoval3, Diego Dios Santos1, Jesús Carlos Fernández López1, Mercedes Freire González1, Guillermo González Arribas1, Genaro Graña Gil1, Natividad Oreiro Villar1, Jose Antonio Pinto Tasende1, Francisco Javier De Toro Santos1, Clara Ventin Rodriguez1, Maite silva díaz3 and Ana Lois Iglesias1, 1Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 2Clinic epidemiology and biostatistics department. Complejo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 3Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC)., A Coruña, Spain

Meeting: ACR Convergence 2023

Keywords: classification criteria, comparative effectiveness, giant cell arteritis, Ultrasound, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant cell arteritis (GCA) affects large and medium size arteries. Biopsy was considered the gold standard in the diagnosis1, but in the last years other techniques are being implemented like temporal and axillar arteries ultrasound (US) with a good performance being included in the 2022 ACR GCA classification criteria2. To improve the diagnosis of these patients a Pretest Probability Score (Southend) (PPS) has been developed3,stratifying patients into 3 different risk groups. The aim was to study the performance of the different tools available for the diagnosis of GCA: PPS, vascular ultrasound, and biopsy of Temporal Artery.

Methods: Retrospective study of the patients referred to our Rheumatology Department with GCA suspicion from January 2019 to October 2022. Demographic and clinical variables including the ones from the PPS were collected.Exploration of the 3 branches of temporal artery and axillar artery bilaterally was performed by grey scale and Color Doppler US (Esaote MylabSix probe 10-22 Hz) evaluating the halo sign and the intima-media thicknes4.PPS and US were carried out in all patients referred. Biopsy was performed in the necessary cases. Final GCA diagnosis was performed according to the rheumatologist decision (clinical diagnosis). A descriptive analysis of the sample was performed. Quantitative variables are expressed as mean (±SD) and qualitative ones as absolute frequencies and percentage. A comparative analysis was performed according to clinical diagnosis. The comparison of means was carried out using the Student’s T or Mann-Whitney U test. The association between qualitative variables was analyzed using Chi-square test. The agreement between the different tests was analyzed using Kappa index. The predictive capacity of the different diagnostic tests is evaluated using ROC curves, providing their AUC, and the sensitivity and specificity values.

Results: Patients (97) with suspected GCA were included, 59.79% women, with a mean age of 74.4 (±9.69). Final diagnosis attending to clinical criteria and other tests was made in 23 patients (23.7%). In GCA compared with non GCA patients showed more frequently and statistical significance: headache, scalp hypersensitivity, facial pain, jaw claudication and changes on temporal artery. Ultrasound was positive in 91.3% (n=21) GCA patients, from them 61.90% had a positive biopsy (Table 1). Area under ROC curve (AUC), sensitivity and specificity for PPS were 0.83 (0.75-0.92), 78.3% and 78.4%, respectively, for US were 0.91 (0.84-0.99), 91.3% and 91.8%, and for biopsy, 0.81 (0.67-0.94), 61.9% and 100%. Data from the combination of PPS+US showed an AUC of 0.96 (0.92-1) (sensitivity 91.3% and specificity 94.5%). Combination of PPS+biopsy showed an AUC of 0.90 (sensitivity 71.4% and specificity 91.2%) (Figure 1).

Conclusion: The combination of US with PPS value improves the individual predictive capacity of each these diagnostic techniques.

Supporting image 1

Table 1. Descriptive analysis of the sample (n=97) comparing the main characteristics in GCA and non-GCA.

Supporting image 2

Figure 1. AUC of the different diagnostic tests studied (probability pretest score, ultrasound of temporal artery and combination).


Disclosures: M. San José Méndez: None; U. Couto Lareo: None; V. Balboa Barreiro: None; F. Blanco: None; B. de aspe de la iglesia: None; A. Atanes Sandoval: None; D. Dios Santos: None; J. Fernández López: None; M. Freire González: None; G. González Arribas: None; G. Graña Gil: None; N. Oreiro Villar: None; J. Pinto Tasende: None; F. De Toro Santos: None; C. Ventin Rodriguez: None; M. silva díaz: None; A. Lois Iglesias: None.

To cite this abstract in AMA style:

San José Méndez M, Couto Lareo U, Balboa Barreiro V, Blanco F, de aspe de la iglesia B, Atanes Sandoval A, Dios Santos D, Fernández López J, Freire González M, González Arribas G, Graña Gil G, Oreiro Villar N, Pinto Tasende J, De Toro Santos F, Ventin Rodriguez C, silva díaz M, Lois Iglesias A. Evaluation of the Pretest Probability Score, Ultrasound and Biopsy on GCA Diagnose: Data from Real Clinical Practice [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/evaluation-of-the-pretest-probability-score-ultrasound-and-biopsy-on-gca-diagnose-data-from-real-clinical-practice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluation-of-the-pretest-probability-score-ultrasound-and-biopsy-on-gca-diagnose-data-from-real-clinical-practice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology